Literature DB >> 29370356

Moving Forward With Treatment of Gonorrhea for Users of Human Immunodeficiency Virus Preexposure Prophylaxis Given the Threat of Antimicrobial Resistance.

Samuel M Jenness1, Kevin M Weiss1, Steven M Goodreau2, Thomas Gift3, Harrell Chesson3, Karen W Hoover4, Dawn K Smith4, Albert Y Liu5, Patrick S Sullivan1, Eli S Rosenberg6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29370356      PMCID： PMC6005146          DOI： 10.1093/cid/ciy050

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  9 in total

1.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

2.  Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study.

Authors:  Samuel M Jenness; Kevin M Weiss; Steven M Goodreau; Thomas Gift; Harrell Chesson; Karen W Hoover; Dawn K Smith; Albert Y Liu; Patrick S Sullivan; Eli S Rosenberg
Journal:  Clin Infect Dis       Date:  2017-09-01       Impact factor: 9.079

3.  Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.

Authors:  Robert D Kirkcaldy; Alesia Harvey; John R Papp; Carlos Del Rio; Olusegun O Soge; King K Holmes; Edward W Hook; Grace Kubin; Stefan Riedel; Jonathan Zenilman; Kevin Pettus; Tremeka Sanders; Samera Sharpe; Elizabeth Torrone
Journal:  MMWR Surveill Summ       Date:  2016-07-15

4.  Risks of Antimicrobial Resistance in N. gonorrhoeae Associated with Intensive Screening Programs in Pre-Exposure Prophylaxis Programs.

Authors:  Chris Kenyon
Journal:  Clin Infect Dis       Date:  2018-06-18       Impact factor: 9.079

Review 5.  Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting.

Authors:  Monica Fung; Katherine C Scott; Charlotte K Kent; Jeffrey D Klausner
Journal:  Sex Transm Infect       Date:  2006-12-13       Impact factor: 3.519

6.  Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion.

Authors:  Kyle T Bernstein; Julia L Marcus; Giuliano Nieri; Susan S Philip; Jeffrey D Klausner
Journal:  J Acquir Immune Defic Syndr       Date:  2010-04-01       Impact factor: 3.731

7.  Fitness cost and benefit of antimicrobial resistance in Neisseria gonorrhoeae: Multidisciplinary approaches are needed.

Authors:  Magnus Unemo; Christian L Althaus
Journal:  PLoS Med       Date:  2017-10-31       Impact factor: 11.069

8.  Antibiotic-Resistant Neisseria gonorrhoeae Spread Faster with More Treatment, Not More Sexual Partners.

Authors:  Stephanie M Fingerhuth; Sebastian Bonhoeffer; Nicola Low; Christian L Althaus
Journal:  PLoS Pathog       Date:  2016-05-19       Impact factor: 6.823

9.  Impact of Rapid Susceptibility Testing and Antibiotic Selection Strategy on the Emergence and Spread of Antibiotic Resistance in Gonorrhea.

Authors:  Ashleigh R Tuite; Thomas L Gift; Harrell W Chesson; Katherine Hsu; Joshua A Salomon; Yonatan H Grad
Journal:  J Infect Dis       Date:  2017-11-27       Impact factor: 5.226
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.